Correlation Between Transcode Therapeutics and Creative Medical

Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Creative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Creative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transcode Therapeutics and Creative Medical Technology, you can compare the effects of market volatilities on Transcode Therapeutics and Creative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Creative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Creative Medical.

Diversification Opportunities for Transcode Therapeutics and Creative Medical

0.59

Correlation Coefficient

Transcode Therapeutics  Creative Medical

Very weak diversification

The 3 months correlation between Transcode and Creative is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Creative Medical Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Creative Medical Tec and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Creative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Creative Medical Tec has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Creative Medical go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and Creative Medical

Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Creative Medical. But the stock apears to be less risky and, when comparing its historical volatility, Transcode Therapeutics is 1.22 times less risky than Creative Medical. The stock trades about -0.01 of its potential returns per unit of risk. The Creative Medical Technology is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  329.00  in Creative Medical Technology on August 18, 2025 and sell it today you would lose (14.00) from holding Creative Medical Technology or give up 4.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Transcode Therapeutics  vs.  Creative Medical Technology

Transcode Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Transcode Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Creative Medical Tec

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Creative Medical Technology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent essential indicators, Creative Medical may actually be approaching a critical reversion point that can send shares even higher in December 2025.

Pair Trading with Transcode Therapeutics and Creative Medical

The main advantage of trading using opposite Transcode Therapeutics and Creative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Creative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creative Medical will offset losses from the drop in Creative Medical's long position.

The idea behind Transcode Therapeutics and Creative Medical Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.